share_log

HC Wainwright & Co. Maintains Buy on Belite Bio, Raises Price Target to $59

Benzinga ·  Nov 7, 2023 00:46

HC Wainwright & Co. analyst Yi Chen maintains Belite Bio (NASDAQ:BLTE) with a Buy and raises the price target from $55 to $59.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment